Skip to main content
. 2017 Jul 19;7:5824. doi: 10.1038/s41598-017-05163-w

Figure 3.

Figure 3

RARα antagonists reduce ApoC-III inhibition by RAR agonist. Hep3B cells were pretreated with various RARα antagonists 2 hrs before RAR agonist stimulation; cells were then incubated for 3 days and secreted ApoC-III protein levels were measured using the ApoC-III HTRF assay. (a) LGD1550 co-treated with 10 nM of BMS493, an RAR pan antagonist. (b) LGD1550 co-treated with 50 nM of BMS614, an RARα specific antagonist. (c) LGD1550 with 100 nM of MM11253, a specific RARγ agonist. (d) RARα in Hep3B cells were silenced by transient transfection with siRNA. Cells with or without siRARα were stimulated with 1 μM of LGD1550 and ApoC-III levels were measured after 3-day incubation. Representative triplicate data is shown from at least three independent experiments.